Escalon Medical(ESMC)

Focus: Escalon Medical is a public biotechnology company specializing in ophthalmology devices, headquartered in Wayne, PA. The company operates as a focused medical device player in a niche therapeutic area with approximately $12M in annual revenue.

Ophthalmology

Profile data last refreshed 19h ago · AI intelligence enriched 2w ago

Funding Stage

PUBLIC

Open Jobs

About Escalon Medical

AI assessmentNot Hiring

No open roles listed right now. Follow Escalon Medical to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

1/9 — Limited

Company HealthSolid

Pipeline

Early-stage

0 total

LOE Risk

Protected

No near-term cliffs

Hiring

0 open

Revenue

$12M

FY2025

Open Jobs (0)

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts

SEC Filings: 2 available

Financials (FY2025)

Help build intelligence for Escalon Medical

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Focused expertise in ophthalmology devices offers deep domain specialization rare in larger organizations
Public company status provides liquidity and potential equity upside for long-term employees
Lean R&D structure (6% intensity) suggests efficient operations without bloated overhead

Watch Out For

Minimal R&D investment ($688K in FY2025) signals limited pipeline development and innovation velocity
Stagnant revenue ($12M flat YoY) with declining cash position ($890K in FY2025 vs. $594K prior year) raises sustainability concerns
Zero active clinical trials and no disclosed pipeline programs indicate limited near-term growth catalysts
Currently reporting zero active job openings suggests limited hiring and potential organizational contraction

Generated by Claude from Escalon Medical's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Revenue

$12M2%

R&D Spend

$688K(6%)16%

Net Income

-$125K

Cash

$890K

Pro Feature

Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.

Upgrade to Pro — $25/mo